{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T21:17:15Z","timestamp":1791062235205,"version":"4.1.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Dutch government"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1016\/j.vaccine.2010.12.033","type":"journal-article","created":{"date-parts":[[2010,12,26]],"date-time":"2010-12-26T04:09:00Z","timestamp":1293336540000},"page":"1431-1437","source":"Crossref","is-referenced-by-count":47,"title":["Identifying long-term memory B-cells in vaccinated children despite waning antibody levels specific for Bordetella pertussis proteins"],"prefix":"10.1016","volume":"29","author":[{"given":"Lotte H.","family":"Hendrikx","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kemal","family":"\u00d6zt\u00fcrk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lia G.H.","family":"de Rond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinier H.","family":"Veenhoven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth A.M.","family":"Sanders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy A.M.","family":"Berbers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Marie","family":"Buisman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.vaccine.2010.12.033_bib0005","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1097\/INF.0b013e318161a2b9","article-title":"Impact of acellular pertussis preschool booster vaccination on disease burden of pertussis in The Netherlands","volume":"27","author":"de Greeff","year":"2008","journal-title":"Pediatr Infect Dis J"},{"issue":"Suppl. 5","key":"10.1016\/j.vaccine.2010.12.033_bib0010","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1097\/01.inf.0000160909.24879.e6","article-title":"Pertussis sources of infection and routes of transmission in the vaccination era","volume":"24","author":"Schellekens","year":"2005","journal-title":"Pediatr Infect Dis J"},{"issue":"8986","key":"10.1016\/j.vaccine.2010.12.033_bib0015","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1016\/S0140-6736(95)92343-8","article-title":"Pertussis in adults: frequency of transmission after household exposure","volume":"346","author":"Wirsing von Konig","year":"1995","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.vaccine.2010.12.033_bib0020","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S0264-410X(00)00253-X","article-title":"Investigation of cellular and humoral immune responses to whole cell and acellular pertussis vaccines","volume":"19","author":"Canthaboo","year":"2000","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2010.12.033_bib0025","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1086\/315527","article-title":"Protection against Bordetella pertussis in mice in the absence of detectable circulating antibody: implications for long-term immunity in children","volume":"181","author":"Mahon","year":"2000","journal-title":"J Infect Dis"},{"issue":"9091","key":"10.1016\/j.vaccine.2010.12.033_bib0030","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/S0140-6736(97)06508-2","article-title":"Randomised controlled trial of two-component, three-component, and five-component acellular pertussis vaccines compared with whole-cell pertussis vaccine. Ad Hoc Group for the Study of Pertussis Vaccines","volume":"350","author":"Olin","year":"1997","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.vaccine.2010.12.033_bib0035","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.vaccine.2009.09.102","article-title":"Long-term presence of memory B-cells specific for different vaccine components","volume":"28","author":"Buisman","year":"2009","journal-title":"Vaccine"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2010.12.033_bib0040","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jim.2008.02.018","article-title":"Development and validation of a multiplex immunoassay for the simultaneous determination of serum antibodies to Bordetella pertussis, diphtheria and tetanus","volume":"335","author":"van Gageldonk","year":"2008","journal-title":"J Immunol Methods"},{"issue":"6","key":"10.1016\/j.vaccine.2010.12.033_bib0045","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1128\/CDLI.11.6.1045-1053.2004","article-title":"Establishment of diagnostic cutoff points for levels of serum antibodies to pertussis toxin, filamentous hemagglutinin, and fimbriae in adolescents and adults in the United States","volume":"11","author":"Baughman","year":"2004","journal-title":"Clin Diagn Lab Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2010.12.033_bib0050","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1128\/JCM.38.2.800-806.2000","article-title":"Specificity and sensitivity of high levels of immunoglobulin G antibodies against pertussis toxin in a single serum sample for diagnosis of infection with Bordetella pertussis","volume":"38","author":"de Melker","year":"2000","journal-title":"J Clin Microbiol"},{"issue":"5","key":"10.1016\/j.vaccine.2010.12.033_bib0055","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/PL00015016","article-title":"Evaluation of a single-sample serological technique for diagnosing pertussis in unvaccinated children","volume":"18","author":"Wirsing von Konig","year":"1999","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"19","key":"10.1016\/j.vaccine.2010.12.033_bib0060","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1056\/NEJMoa066092","article-title":"Duration of humoral immunity to common viral and vaccine antigens","volume":"357","author":"Amanna","year":"2007","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.vaccine.2010.12.033_bib0065","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1002\/eji.200839129","article-title":"Clonal dissection of the human memory B-cell repertoire following infection and vaccination","volume":"39","author":"Pinna","year":"2009","journal-title":"Eur J Immunol"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2010.12.033_bib0070","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jim.2003.12.015","article-title":"Tracking human antigen-specific memory B cells: a sensitive and generalized ELISPOT system","volume":"286","author":"Crotty","year":"2004","journal-title":"J Immunol Methods"},{"issue":"10","key":"10.1016\/j.vaccine.2010.12.033_bib0075","doi-asserted-by":"crossref","first-page":"4969","DOI":"10.4049\/jimmunol.171.10.4969","article-title":"Cutting edge: long-term B cell memory in humans after smallpox vaccination","volume":"171","author":"Crotty","year":"2003","journal-title":"J Immunol"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2010.12.033_bib0080","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.jim.2006.07.016","article-title":"Detection of memory B lymphocytes specific to hepatitis B virus (HBV) surface antigen (HBsAg) from HBsAg-vaccinated or HBV-immunized subjects by ELISPOT assay","volume":"315","author":"Tuaillon","year":"2006","journal-title":"J Immunol Methods"},{"issue":"2","key":"10.1016\/j.vaccine.2010.12.033_bib0085","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.virol.2008.08.004","article-title":"Characterization of rotavirus specific B cells and their relation with serological memory","volume":"380","author":"Rojas","year":"2008","journal-title":"Virology"},{"issue":"1","key":"10.1016\/j.vaccine.2010.12.033_bib0090","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1128\/JVI.01957-06","article-title":"Comparison of the influenza virus-specific effector and memory B-cell responses to immunization of children and adults with live attenuated or inactivated influenza virus vaccines","volume":"81","author":"Sasaki","year":"2007","journal-title":"J Virol"},{"issue":"6","key":"10.1016\/j.vaccine.2010.12.033_bib0095","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1086\/591094","article-title":"Direct ex vivo evaluation of long-lived protective antiviral memory B cell responses against hepatitis B virus","volume":"198","author":"Ward","year":"2008","journal-title":"J Infect Dis"},{"issue":"8","key":"10.1016\/j.vaccine.2010.12.033_bib0100","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.1182\/blood-2006-01-009282","article-title":"CRM197-conjugated serogroup C meningococcal capsular polysaccharide, but not the native polysaccharide, induces persistent antigen-specific memory B cells","volume":"108","author":"Kelly","year":"2006","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.vaccine.2010.12.033_bib0105","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1128\/CVI.00336-07","article-title":"Serotype specific and age dependent generation of pneumococcal polysaccharide specific memory B cells and antibody response to immunization with a pneumococcal conjugate vaccine","volume":"15","author":"Clutterbuck","year":"2007","journal-title":"Clin Vaccine Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2010.12.033_bib0110","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.4049\/jimmunol.180.4.2165","article-title":"The magnitude of the antibody and memory B cell responses during priming with a protein\u2013polysaccharide conjugate vaccine in human infants is associated with the persistence of antibody and the intensity of booster response","volume":"180","author":"Blanchard Rohner","year":"2008","journal-title":"J Immunol"},{"issue":"46\u201347","key":"10.1016\/j.vaccine.2010.12.033_bib0115","doi-asserted-by":"crossref","first-page":"5359","DOI":"10.1016\/j.vaccine.2005.06.009","article-title":"Pertussis antitoxin decay after vaccination with DTPa. Response to a first booster dose 3 1\/2\u20136 1\/2 years after the third vaccine dose","volume":"23","author":"Hallander","year":"2005","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.vaccine.2010.12.033_bib0120","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1016\/j.vaccine.2006.10.048","article-title":"Long-term humoral and cell-mediated immunity after acellular pertussis vaccination compares favourably with whole-cell vaccines 6 years after booster vaccination in the second year of life","volume":"25","author":"Guiso","year":"2007","journal-title":"Vaccine"},{"issue":"47","key":"10.1016\/j.vaccine.2010.12.033_bib0125","doi-asserted-by":"crossref","first-page":"6530","DOI":"10.1016\/j.vaccine.2009.08.052","article-title":"IgG responses after booster vaccination with different pertussis vaccines in Dutch children 4 years of age: effect of vaccine antigen content","volume":"27","author":"Hendrikx","year":"2009","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.vaccine.2010.12.033_bib0130","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1086\/514338","article-title":"Immunity to pertussis 5 years after booster immunization during adolescence","volume":"44","author":"Edelman","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2010.12.033_bib0135","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S0022-3476(98)70395-6","article-title":"Antibody responses and persistence in the two years after immunization with two acellular vaccines and one whole-cell vaccine against pertussis","volume":"132","author":"Giuliano","year":"1998","journal-title":"J Pediatr"},{"key":"10.1016\/j.vaccine.2010.12.033_bib0140","first-page":"307","article-title":"Cell-mediated immunity after pertussis vaccination and after natural infection","volume":"89","author":"Zepp","year":"1997","journal-title":"Dev Biol Stand"},{"issue":"4","key":"10.1016\/j.vaccine.2010.12.033_bib0145","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1097\/00006454-199904000-00012","article-title":"Cell-mediated immune responses to antigens of Bordetella pertussis and protection against pertussis in school children","volume":"18","author":"Tran Minh","year":"1999","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2010.12.033_bib0150","doi-asserted-by":"crossref","first-page":"6929","DOI":"10.1016\/j.vaccine.2008.09.064","article-title":"Differences of humoral and cellular immune response to an acellular pertussis booster in adolescents with a whole cell or acellular primary vaccination","volume":"16","author":"Rieber","year":"2008","journal-title":"Vaccine"},{"issue":"23","key":"10.1016\/j.vaccine.2010.12.033_bib0155","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1001\/jama.294.23.3019","article-title":"Immunological memory: the role of B cells in long-term protection against invasive bacterial pathogens","volume":"294","author":"Kelly","year":"2005","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.vaccine.2010.12.033_bib0160","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.vaccine.2007.11.047","article-title":"Improving the cellular pertussis vaccine: increased potency and consistency","volume":"26","author":"Thalen","year":"2008","journal-title":"Vaccine"},{"issue":"3\u20134","key":"10.1016\/j.vaccine.2010.12.033_bib0165","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S0264-410X(01)00328-0","article-title":"Acute and long-term effects of booster immunisation on frequencies of antigen-specific memory B-lymphocytes","volume":"20","author":"Nanan","year":"2001","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2010.12.033_bib0170","doi-asserted-by":"crossref","first-page":"3342","DOI":"10.4049\/jimmunol.162.6.3342","article-title":"B cell maintenance in aged mice reflects both increased B cell longevity and decreased B cell generation","volume":"162","author":"Kline","year":"1999","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2010.12.033_bib0175","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.clim.2008.11.008","article-title":"Memory B-cells in healthy and antibody-deficient children","volume":"131","author":"Huck","year":"2009","journal-title":"Clin Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2010.12.033_bib0180","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.clim.2009.05.020","article-title":"Refined characterization and reference values of the pediatric T- and B-cell compartments","volume":"133","author":"van Gent","year":"2009","journal-title":"Clin Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2010.12.033_bib0185","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/nri2508","article-title":"B-cell responses to vaccination at the extremes of age","volume":"9","author":"Siegrist","year":"2009","journal-title":"Nat Rev Immunol"},{"issue":"Suppl. 2","key":"10.1016\/j.vaccine.2010.12.033_bib0190","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1016\/S0264-410X(03)00198-1","article-title":"Antigen dependent and independent mechanisms that sustain serum antibody levels","volume":"21","author":"Traggiai","year":"2003","journal-title":"Vaccine"},{"issue":"5601","key":"10.1016\/j.vaccine.2010.12.033_bib0195","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1126\/science.1076071","article-title":"Maintenance of serological memory by polyclonal activation of human memory B cells","volume":"298","author":"Bernasconi","year":"2002","journal-title":"Science"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10017858?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10017858?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,4]],"date-time":"2023-06-04T12:31:52Z","timestamp":1685881912000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X10017858"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2]]},"references-count":39,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["S0264410X10017858"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2010.12.033","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,2]]}}}